570 related articles for article (PubMed ID: 36499613)
21. Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.
Kandimalla R; Thirumala V; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1078-1089. PubMed ID: 27567931
[TBL] [Abstract][Full Text] [Related]
22. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes.
Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
J Pathol; 2011 Sep; 225(1):54-62. PubMed ID: 21598254
[TBL] [Abstract][Full Text] [Related]
23. Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease.
Jash K; Gondaliya P; Kirave P; Kulkarni B; Sunkaria A; Kalia K
Drug Dev Res; 2020 Apr; 81(2):144-164. PubMed ID: 31820484
[TBL] [Abstract][Full Text] [Related]
24. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
Gupta S; Yadav K; Mantri SS; Singhal NK; Ganesh S; Sandhir R
Mol Neurobiol; 2018 Dec; 55(12):8916-8935. PubMed ID: 29611103
[TBL] [Abstract][Full Text] [Related]
25. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
de la Monte SM
Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
[TBL] [Abstract][Full Text] [Related]
26. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
27. The pancreas-brain axis: insight into disrupted mechanisms associating type 2 diabetes and Alzheimer's disease.
Desai GS; Zheng C; Geetha T; Mathews ST; White BD; Huggins KW; Zizza CA; Broderick TL; Babu JR
J Alzheimers Dis; 2014; 42(2):347-56. PubMed ID: 24858405
[TBL] [Abstract][Full Text] [Related]
28. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
[TBL] [Abstract][Full Text] [Related]
30. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
31. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity.
Jantrapirom S; Nimlamool W; Chattipakorn N; Chattipakorn S; Temviriyanukul P; Inthachat W; Govitrapong P; Potikanond S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138327
[TBL] [Abstract][Full Text] [Related]
32. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
33. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
Ribe EM; Lovestone S
J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
[TBL] [Abstract][Full Text] [Related]
34. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
35. Linking insulin with Alzheimer's disease: emergence as type III diabetes.
Ahmed S; Mahmood Z; Zahid S
Neurol Sci; 2015 Oct; 36(10):1763-9. PubMed ID: 26248483
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
37. Induction of Brain Insulin Resistance and Alzheimer's Molecular Changes by Western Diet.
Mietelska-Porowska A; Domańska J; Want A; Więckowska-Gacek A; Chutorański D; Koperski M; Wojda U
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563135
[TBL] [Abstract][Full Text] [Related]
38. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update.
Chauhan N; Paliwal S; Jain S; Verma K; Paliwal S; Sharma S
Mini Rev Med Chem; 2022; 22(22):2881-2895. PubMed ID: 35450523
[TBL] [Abstract][Full Text] [Related]
39. Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.
Bhattamisra SK; Shin LY; Saad HIBM; Rao V; Candasamy M; Pandey M; Choudhury H
CNS Neurol Disord Drug Targets; 2020; 19(3):174-183. PubMed ID: 32418534
[TBL] [Abstract][Full Text] [Related]
40. Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.
Bitel CL; Kasinathan C; Kaswala RH; Klein WL; Frederikse PH
J Alzheimers Dis; 2012; 32(2):291-305. PubMed ID: 22785400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]